Bioventus Announced It Has Entered Into A Definitive Agreement To Acquire Misonix In A Cash-And-Stock Transaction. Misonix Stockholders Will Receive Either 1.6839 Shares Of Bioventus Class A Common Stock Or $28 In Cash Without Interest Per Held Share.